It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
In drug discovery, efficient screening of protein-drug interactions (PDIs) is hampered by the limitations of current biophysical approaches. Here, we develop a biological nanopore sensor for single-molecule detection of proteins and PDIs using the pore-forming toxin YaxAB. Using this YaxAB nanopore, we demonstrate label-free, single-molecule detection of interactions between the anticancer Bcl-xL protein and small-molecule drugs as well as the Bak-BH3 peptide. The long funnel-shaped structure and nanofluidic characteristics of the YaxAB nanopore enable the electro-osmotic trapping of diverse folded proteins and high-resolution monitoring of PDIs. Distinctive nanopore event distributions observed in the two-dimensional (ΔI/Io-versus-IN) plot illustrate the ability of the YaxAB nanopore to discriminate individual small-molecule drugs bound to Bcl-xL from non-binders. Taken together, our results present the YaxAB nanopore as a robust platform for label-free, ultrasensitive, single-molecule detection of PDIs, opening up a possibility for low-cost, highly efficient drug discovery against diverse drug targets.
Efficient screening of protein-drug interactions (PDIs) has been impeded by the limitations of current biophysical approaches. Here, the authors present a funneled YaxAB nanopore sensor which allows label-free, single-molecule detection of proteins and PDIs.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details






1 Division of Biomedical Research, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Disease Target Structure Research Center, Daejeon, Republic of Korea (GRID:grid.249967.7) (ISNI:0000 0004 0636 3099); Critical Diseases Diagnostics Convergence Research Center, KRIBB, Daejeon, Republic of Korea (GRID:grid.249967.7) (ISNI:0000 0004 0636 3099)
2 Division of Biomedical Research, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Disease Target Structure Research Center, Daejeon, Republic of Korea (GRID:grid.249967.7) (ISNI:0000 0004 0636 3099); KRIBB School of Bioscience, University of Science and Technology, Department of Proteome Structural Biology, Daejeon, Republic of Korea (GRID:grid.412786.e) (ISNI:0000 0004 1791 8264)
3 Sungkyunkwan University, Department of Physics, Suwon, Republic of Korea (GRID:grid.264381.a) (ISNI:0000 0001 2181 989X)
4 Division of Biomedical Research, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Disease Target Structure Research Center, Daejeon, Republic of Korea (GRID:grid.249967.7) (ISNI:0000 0004 0636 3099)
5 Institute for Basic Science (IBS), Center for Biomolecular and Cellular Structure, Daejeon, Republic of Korea (GRID:grid.410720.0) (ISNI:0000 0004 1784 4496)
6 Institute for Basic Science (IBS), Center for Biomolecular and Cellular Structure, Daejeon, Republic of Korea (GRID:grid.410720.0) (ISNI:0000 0004 1784 4496); Korea Advanced Institute of Science and Technology (KAIST), Graduate School of Medical Science and Engineering, Daejeon, Republic of Korea (GRID:grid.37172.30) (ISNI:0000 0001 2292 0500)
7 Division of Biomedical Research, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Disease Target Structure Research Center, Daejeon, Republic of Korea (GRID:grid.249967.7) (ISNI:0000 0004 0636 3099); Critical Diseases Diagnostics Convergence Research Center, KRIBB, Daejeon, Republic of Korea (GRID:grid.249967.7) (ISNI:0000 0004 0636 3099); KRIBB School of Bioscience, University of Science and Technology, Department of Proteome Structural Biology, Daejeon, Republic of Korea (GRID:grid.412786.e) (ISNI:0000 0004 1791 8264)
8 Division of Biomedical Research, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Disease Target Structure Research Center, Daejeon, Republic of Korea (GRID:grid.249967.7) (ISNI:0000 0004 0636 3099); KRIBB School of Bioscience, University of Science and Technology, Department of Proteome Structural Biology, Daejeon, Republic of Korea (GRID:grid.412786.e) (ISNI:0000 0004 1791 8264); Sungkyunkwan University, School of Pharmacy, Suwon, Republic of Korea (GRID:grid.264381.a) (ISNI:0000 0001 2181 989X)